As of 2025-05-25, the Relative Valuation of Tandem Diabetes Care Inc (TNDM) is (75.41) USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.72 USD, the upside of Tandem Diabetes Care Inc based on Relative Valuation is -464.0%.
The range of the Relative Valuation is (56.74) - (87.02) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 38.0x | 26.0x |
| Forward P/E multiples | 20.5x - 31.5x | 28.6x |
| Fair Price | (56.74) - (87.02) | (75.41) |
| Upside | -373.8% - -520.0% | -464.0% |
| Date | P/E |
| 2025-05-15 | -8.22 |
| 2025-05-14 | -8.27 |
| 2025-05-13 | -8.37 |
| 2025-05-12 | -8.49 |
| 2025-05-09 | -8.32 |
| 2025-05-08 | -8.23 |
| 2025-05-07 | -8.06 |
| 2025-05-06 | -7.72 |
| 2025-05-05 | -7.71 |
| 2025-05-02 | -7.78 |
| 2025-05-01 | -7.23 |
| 2025-04-30 | -6.10 |
| 2025-04-29 | -6.07 |
| 2025-04-28 | -6.32 |
| 2025-04-25 | -6.54 |
| 2025-04-24 | -6.40 |
| 2025-04-23 | -6.00 |
| 2025-04-22 | -5.92 |
| 2025-04-21 | -5.93 |
| 2025-04-17 | -6.10 |
| 2025-04-16 | -6.25 |
| 2025-04-15 | -6.41 |
| 2025-04-14 | -6.16 |
| 2025-04-11 | -6.18 |
| 2025-04-10 | -6.17 |
| 2025-04-09 | -6.37 |
| 2025-04-08 | -5.93 |
| 2025-04-07 | -6.10 |
| 2025-04-04 | -6.11 |
| 2025-04-03 | -6.39 |
| 2025-04-02 | -6.84 |
| 2025-04-01 | -6.78 |
| 2025-03-31 | -6.94 |
| 2025-03-28 | -6.98 |
| 2025-03-27 | -7.17 |
| 2025-03-26 | -7.12 |
| 2025-03-25 | -7.32 |
| 2025-03-24 | -7.46 |
| 2025-03-21 | -7.35 |
| 2025-03-20 | -7.48 |
| 2025-03-19 | -7.46 |
| 2025-03-18 | -7.26 |
| 2025-03-17 | -7.14 |
| 2025-03-14 | -6.94 |
| 2025-03-13 | -6.58 |
| 2025-03-12 | -6.79 |
| 2025-03-11 | -6.48 |
| 2025-03-10 | -6.57 |
| 2025-03-07 | -6.50 |
| 2025-03-06 | -6.78 |